微环境和瘤异质性作为精密瘤学的药理学目标
Stelvio Tonello1,2, Roberta Rolla3,4, Paolo Amedeo Tillio3
1Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.
Pharmaceuticals (Basel, Switzerland)
|June 27, 2025
概括
瘤异质性和瘤微环境是理解癌症进展和耐药性的关键. 对生物标志物和基础生物学的进一步研究将促进精密医学,以更好地治疗癌症.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 精准医学是一门精准的医学.
背景情况:
- 瘤疾病表现出显著的个人间和瘤内异质性 (ITH).
- 复杂的细胞和分子信号网络驱动瘤的发展和进展.
- 瘤微环境 (TME) 在瘤生长,转移和耐药性方面发挥着关键作用.
研究的目的:
- 提供关于瘤异质性的细胞和分子机制的综合文献综述.
- 检查TME在瘤发育和支持中的作用.
- 突出TME和ITH在开发精准医学方法方面的潜力.
主要方法:
- 现有文献的叙述性审查.
- 细胞和分子机制的分析.
- 检查瘤微环境的作用.
主要成果:
- ITH和TME对于了解癌症至关重要,影响瘤生长,转移和耐药性.
- 炎症,细胞招募,细胞因子和缺氧等特定条件有助于TME的建立和瘤的进展.
- 细胞外基质和免疫细胞 (骨髓前体,M2巨细胞) 有助于物理障碍和免疫耐受性.
结论:
- ITH和TME在癌症研究和药理学中起着至关重要的作用,使得人们能够更好地了解癌症与环境之间的沟通.
- 已开发出有针对性的分子剂,但ITH需要新的预后/预测生物标志物 (ctDNA,CTCs) 和基础生物学知识.
- 精准医学为开发新型药物方法和在瘤学中的临床应用提供了一个变革性的机会.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Cancer
49.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


